Gevo Reports Executive Compensation/Leadership Changes on Dec 30
Ticker: GEVO · Form: 8-K · Filed: Jan 3, 2024 · CIK: 1392380
| Field | Detail |
|---|---|
| Company | Gevo, INC. (GEVO) |
| Form Type | 8-K |
| Filed Date | Jan 3, 2024 |
| Risk Level | medium |
| Pages | 2 |
| Reading Time | 3 min |
| Key Dollar Amounts | $0.01, $85,000, $73,500 |
| Sentiment | neutral |
Complexity: simple
Sentiment: neutral
Topics: executive-changes, compensation, corporate-governance
TL;DR
**Gevo just reported executive changes and compensation updates, watch for details!**
AI Summary
Gevo, Inc. filed an 8-K on January 3, 2024, reporting an event that occurred on December 30, 2023. This filing indicates a change in compensatory arrangements for certain officers, as well as potential departures or elections of directors or officers. While specific names and dollar amounts are not detailed in this summary, the filing signals important changes in executive compensation or leadership, which could impact the company's financial health and strategic direction. Investors should pay attention to the full details of this filing to understand how these changes might affect Gevo's future performance and their investment.
Why It Matters
Changes in executive compensation or leadership can signal shifts in company strategy, financial health, or governance, directly impacting investor confidence and stock valuation.
Risk Assessment
Risk Level: medium — Changes in executive compensation or leadership can introduce uncertainty, but without specific details, the immediate risk is moderate.
Analyst Insight
Investors should monitor Gevo's subsequent filings or press releases for specific details on the executive changes and compensation arrangements, as these will provide clarity on the strategic implications and potential financial impact.
Key Numbers
- December 30, 2023 — Earliest Event Date (Indicates when the reported event, likely executive changes or compensation, actually occurred.)
- January 3, 2024 — Filing Date (The date the public was officially notified of the event.)
Key Players & Entities
- Gevo, Inc. (company) — the registrant filing the 8-K
- December 30, 2023 (date) — date of the earliest event reported
- January 3, 2024 (date) — date the 8-K was filed
- Delaware (company) — state of incorporation for Gevo, Inc.
- 001-35073 (dollar_amount) — Commission File Number
- 87-0747704 (dollar_amount) — IRS Employer Identification No.
- 303-858-8358 (dollar_amount) — Registrant's telephone number
Forward-Looking Statements
- Gevo, Inc. will provide more specific details regarding the executive changes and compensatory arrangements in a subsequent filing or press release. (Gevo, Inc.) — high confidence, target: Q1 2024
FAQ
What specific items were reported in this 8-K filing by Gevo, Inc.?
Gevo, Inc. reported information under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers), Item 7.01 (Regulation FD Disclosure), and Item 9.01 (Financial Statements and Exhibits).
When did the earliest event reported in this 8-K filing occur?
The earliest event reported in this 8-K filing occurred on December 30, 2023.
What is Gevo, Inc.'s state of incorporation and Commission File Number?
Gevo, Inc. is incorporated in Delaware and its Commission File Number is 001-35073.
What is the business address and phone number of Gevo, Inc. as listed in the filing?
Gevo, Inc.'s business address is 345 Inverness Drive South, Building C, Suite 310, Englewood, CO 80112, and its telephone number is (303) 858-8358.
What is the primary industry classification for Gevo, Inc. according to the filing?
Gevo, Inc.'s Standard Industrial Classification is Industrial Organic Chemicals [2860].
Filing Stats: 723 words · 3 min read · ~2 pages · Grade level 10.2 · Accepted 2024-01-03 16:12:45
Key Financial Figures
- $0.01 — ch registered Common Stock, par value $0.01 per share GEVO The Nasdaq Stock Ma
- $85,000 — will receive an annual cash retainer of $85,000 and an equity grant valued at $73,500 f
- $73,500 — f $85,000 and an equity grant valued at $73,500 for service as a non-employee director,
Filing Documents
- tm2333985d1_8k.htm (8-K) — 27KB
- tm2333985d1_ex99-1.htm (EX-99.1) — 9KB
- tm2333985d1_ex99-1img001.jpg (GRAPHIC) — 11KB
- tm2333985d1_ex99-1img002.jpg (GRAPHIC) — 4KB
- 0001104659-24-000824.txt ( ) — 232KB
- gevo-20231230.xsd (EX-101.SCH) — 3KB
- gevo-20231230_lab.xml (EX-101.LAB) — 33KB
- gevo-20231230_pre.xml (EX-101.PRE) — 22KB
- tm2333985d1_8k_htm.xml (XML) — 3KB
02.Departure of Directors or Certain
Item 5.02.Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. Effective as of January 2, 2024, the Board of Directors (the "Board") of Gevo, Inc. ("Gevo" or the "Company") approved the appointment of Mary Kathryn (Katie) Ellet to the Board as a Class III director, with a current term that will expire at the annual meeting of stockholders to be held in 2025. Ms. Ellet will receive an annual cash retainer of $85,000 and an equity grant valued at $73,500 for service as a non-employee director, subject to the Company's compensation policy for non-employee directors as specified from time to time by the Board. The equity award will be made pursuant to the Company's Amended and Restated 2010 Stock Incentive Plan. Ms. Ellet will also be eligible to receive annual grants of equity and other compensation consistent with the Company's compensation policy for her service as a non-employee director, as specified from time to time by the Board. Ms. Ellet also entered into the Company's customary form of indemnification agreement upon her appointment to the Board. There are no understandings or arrangements with any person pursuant to which Ms. Ellet was selected as a director, and Ms. Ellet is not party to any related party transaction required to be reported pursuant to Item 404(a) of Regulation S-K. The Board considered the independence of Ms. Ellet under The Nasdaq Stock Market LLC ("Nasdaq") listing standards and concluded that Ms. Ellet is an independent director under the applicable Nasdaq standards.
01. Regulation FD
Item 7.01. Regulation FD. The Company issued the press release attached hereto as Exhibit 99.1 in connection with the appointment of Ms. Ellet to the Board. The information included in this Current Report under Item 7.01, including Exhibit 99.1, is deemed to be "furnished" and shall not be "filed" for purposes of Section 18 of the Exchange Act, or otherwise subject to the liabilities of that section, and is not incorporated by reference into any filing under the Securities Act or the Exchange Act.
01. Financial Statements and Exhibits
Item 9.01. Financial Statements and Exhibits. (d) Exhibits. Exhibit No. Description 99.1 Press Release, dated January 3, 2024 104 Cover Page Interactive Data File (Formatted as Inline XBRL)
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. GEVO, INC. Date: January 3, 2024 By: /s/ E. Cabell Massey E. Cabell Massey Vice President, Legal and Corporate Secretary